Suppr超能文献

女性如何遵循癌症筛查?法国四个地区的研究。

How do women comply with cancer screenings? A study in four regions of France.

机构信息

Normandie univ, UNICAEN, Inserm U1086, ANTICIPE, Caen, 14000, France.

Cancer et expositions environnementales, Univ. Bordeaux, Inserm U1219, EPICENE, Bordeaux, 33000, France.

出版信息

BMC Womens Health. 2023 Apr 21;23(1):190. doi: 10.1186/s12905-023-02311-5.

Abstract

BACKGROUND

This article looks at the behaviour of women facing different cancer screening options available to them from the age of 50 onward. The study was conducted in 2019 in four departments of the French territory with the objective of identifying the factors that influence acceptance of a population-based screening proposal.

METHODS

A questionnaire was sent to women who had received three invitations to organised screenings (OS) for both breast and colorectal cancer. The categories of participants in both OS were designed from data from the regional cancer screening coordination centres in each department. Participation in opportunistic cervical cancer screening was evaluated as self-reported data.

RESULTS

4,634 questionnaires were returned out of the 17,194 sent, giving a global return rate of 27%. The highest rate of return (73.5%) was obtained from women who had participated at least once in both breast and colorectal cancer OS. An intermediate rate was obtained from women participating in breast cancer OS only (18.7%). Poor levels of return came from women who had participated in colorectal cancer OS only (3.6%) and from non-participants (4.1%). Our results suggest that women with lower educational levels tend to be the most regular attendants at OS (50.3%), compared to highly educated women (39.7%). 11.8% of women were overdue in their opportunistic cervical cancer screening. This percentage rose to 35.4% in the category of non-participants. In addition, women's comments provide a better understanding of the reasons for irregular attendance and non-participation.

CONCLUSION

Overall, similar behaviours towards screening were observed in the four departments. Our analysis suggests that participation in one cancer OS increases the likelihood of participating in others. This adhesion could be an interesting lever for raising women's awareness of other cancer screenings.

摘要

背景

本文研究了女性在 50 岁及以上时面对不同癌症筛查选择的行为。该研究于 2019 年在法国四个地区进行,旨在确定影响人群筛查提案接受度的因素。

方法

向已收到三次组织性乳腺癌和结直肠癌筛查(OS)邀请的女性发送了一份问卷。OS 组的参与者类别是根据每个部门区域癌症筛查协调中心的数据设计的。机会性宫颈癌筛查的参与情况则通过自我报告数据进行评估。

结果

在发出的 17194 份问卷中,有 4634 份被退回,总回复率为 27%。回复率最高(73.5%)的是至少参加过一次乳腺癌和结直肠癌 OS 的女性。仅参加过乳腺癌 OS 的女性的回复率为中等(18.7%)。仅参加过结直肠癌 OS 的女性(3.6%)和未参与者(4.1%)的回复率较低。我们的结果表明,与高学历女性(39.7%)相比,教育程度较低的女性更倾向于定期参加 OS(50.3%)。11.8%的女性错过了机会性宫颈癌筛查。在未参与者中,这一比例上升到 35.4%。此外,女性的评论提供了对不规则出席和不参与原因的更好理解。

结论

总体而言,四个地区的筛查行为相似。我们的分析表明,参加一次癌症 OS 会增加参加其他癌症 OS 的可能性。这种参与度可能是提高女性对其他癌症筛查意识的一个有趣的切入点。

相似文献

1
How do women comply with cancer screenings? A study in four regions of France.
BMC Womens Health. 2023 Apr 21;23(1):190. doi: 10.1186/s12905-023-02311-5.
5
Organised screening for cervical cancer in France: a cost-effectiveness assessment.
BMJ Open. 2017 Oct 6;7(10):e014626. doi: 10.1136/bmjopen-2016-014626.
7
Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
J Womens Health (Larchmt). 2020 Jul;29(7):996-1006. doi: 10.1089/jwh.2019.7739. Epub 2020 Jan 10.
8
Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
Eur J Cancer. 2022 Nov;175:180-186. doi: 10.1016/j.ejca.2022.08.018. Epub 2022 Sep 17.

引用本文的文献

本文引用的文献

2
Systematic reviews as a "lens of evidence": Determinants of participation in breast cancer screening.
J Med Screen. 2021 Jun;28(2):70-79. doi: 10.1177/0969141320930743. Epub 2020 Jun 9.
3
Autonomous and informed decision-making: The case of colorectal cancer screening.
PLoS One. 2020 May 29;15(5):e0233308. doi: 10.1371/journal.pone.0233308. eCollection 2020.
5
Understanding barriers and facilitators to participation in colorectal cancer screening: A French qualitative study.
J Health Psychol. 2021 Oct;26(12):2260-2277. doi: 10.1177/1359105320909883. Epub 2020 Mar 13.
6
Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France.
PLoS One. 2020 Feb 13;15(2):e0228660. doi: 10.1371/journal.pone.0228660. eCollection 2020.
7
Concurrent participation in screening for cervical, breast, and bowel cancer in England.
J Med Screen. 2020 Mar;27(1):9-17. doi: 10.1177/0969141319871977. Epub 2019 Sep 16.
9
Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial.
PLoS One. 2019 Mar 26;14(3):e0214057. doi: 10.1371/journal.pone.0214057. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验